Focused Wealth Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100
| Closed | -$2.96K | – | 1050 |
|
|
2023
Q4 | $2.96K | Hold |
100
| – | – | ﹤0.01% | 726 |
|
|
2023
Q3 | $1.59K | Hold |
100
| – | – | ﹤0.01% | 801 |
|
|
2023
Q2 | $1.89K | Hold |
100
| – | – | ﹤0.01% | 808 |
|
|
2023
Q1 | $384 | Hold |
100
| – | – | ﹤0.01% | 955 |
|
|
2022
Q4 | $496 | Hold |
100
| – | – | ﹤0.01% | 949 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 1090 |
|
|
2022
Q2 | $0 | Sell |
100
-25
| -20% | -$109 | ﹤0.01% | 1117 |
|
|
2022
Q1 | $1K | Hold |
125
| – | – | ﹤0.01% | 961 |
|
|
2021
Q4 | $1K | Hold |
125
| – | – | ﹤0.01% | 955 |
|
|
2021
Q3 | $1K | Buy |
125
+25
| +25% | +$144 | ﹤0.01% | 967 |
|
|
2021
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 907 |
|
|
2021
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 889 |
|
|
2020
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 799 |
|
|
2020
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 895 |
|
|
2020
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 851 |
|
|
2020
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 796 |
|
|
2019
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 696 |
|
|
2019
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 794 |
|
|
2019
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 826 |
|
|
2019
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 767 |
|
|
2018
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 768 |
|
|
2018
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 636 |
|
|
2018
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 626 |
|
|
2018
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 676 |
|
|
2017
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 661 |
|
|
2017
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 630 |
|
|
2017
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 685 |
|
|
2017
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 740 |
|
|
2016
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 743 |
|
|
2016
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 706 |
|
|
2016
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 732 |
|
|
2016
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 626 |
|
|
2015
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 651 |
|
|
2015
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 654 |
|
|
2015
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 635 |
|
|
2015
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 650 |
|
|
2014
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 634 |
|
|
2014
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 659 |
|
|
2014
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 642 |
|
|
2014
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 607 |
|
|
2013
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 601 |
|
|
2013
Q3 | $2K | Buy |
+100
| New | +$1.76K | ﹤0.01% | 539 |
|
Other funds holding IMGN
Focused Wealth Management's IMGN Position: Q1 2024 in Review
Focused Wealth Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 100 shares — an estimated $2.96K sold.
Focused Wealth Management first reported a position in IMGN in Q3 2013 and held it in 42 quarters. The position peaked at $2.96K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Focused Wealth Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Focused Wealth Management sold 100 Immunogen Inc shares in Q1 2024, an estimated $2.96K.
- Focused Wealth Management first reported a position in Immunogen Inc in Q3 2013 and held it in 42 quarters.
- Focused Wealth Management's Immunogen Inc position peaked at $2.96K in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.